Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?

Journal of Neuro-Oncology

Volumn 121, Issue 2, 2015, Pages 303-309

  Amin, Amr ^a   Mustafa, M ^a   Abd El Hadi, E ^a   Monier, A ^a   Badwey, A ^a   Saad, E ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Glioma multiforme; Prognosis; Survival; Tc 99m (V) DMSA brain SPECT

Indexed keywords

SUCCIMER TC 99M; TEMOZOLOMIDE; RADIOPHARMACEUTICAL AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG DOSE ESCALATION; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MALE; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NEUROSURGERY; OVERALL SURVIVAL; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN; BRAIN NEOPLASMS; DIAGNOSTIC USE; KAPLAN MEIER METHOD; MIDDLE AGED; PROCEDURES; PROGNOSIS; SCINTISCANNING;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84925487119     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1633-9     Document Type: Article

References (25)

1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 10(352):987–996
2. Scott JN, Rewcastle NB, Brasher PM et al (1999) Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 46:183–188
3. Liu Y, Shete S, Etzel CJ et al (2010) Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival. J Clin Oncol 28:2467–2474
4. Curran WJ Jr, Scott JB, Horton J et al (1993) Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:690–691
5. Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198
6. Shinojima N, Kochi M, Hamada J et al (2004) The influence of sex and the presence of giant cells on postoperative long-term survival in adult patients with supra-tentorial glioblastoma multiforme. J Neurosurg 101:219–226
7. McLendon R, Friedman A, Bigner D et al (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068
8. Amin A, Moustafa H, Ahmed E, El-Toukhy M (2012) Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results. J Neurooncol 106:579–587
9. Alexiou GA, Tsiouris S, Kyritsis AP, Fotakopoulos G, Goussia A, Voulgaris S, Fotopoulos AD (2010) The value of 99mTc-tetrofosmin brain SPECT in predicting survival in patients with glioblastoma multiforme. J Nucl Med 51:1923–1926
10. Denoyer D, Perek N, Le Jeune N, Frere D, Dubois F (2004) Evidence that 99mTc-(V)-DMSA uptake is mediated by NaPi cotransporter type III in tumour cell lines. Eur J Nucl Med Mol Imaging 31:77–84
11. Denoyer D, Perek N, Le Jeune N, Cornillon J, Dubois F (2005) Correlation between 99mTc-(V)-DMSA uptake and constitutive level of phosphorylated focal adhesion kinase in an in vitro model of cancer cell lines. Eur J Nucl Med Mol Imaging 32:820–827
12. Tsiouris S, Pirmettis I, Chatzipanagiotou T, Ptohis N, Papantoniou V (2007) Pentavalent technetium-99m dimercaptosuccinic acid 99mTc-(V) DMSA brain scintitomography a plausible non-invasive depicter of glioblastoma proliferation and therapy response. J Neurooncol 85:291–295
13. Hirano T, Tomiyoshi K, Zhang YJ, Ishida T, Inoue T, Endo K (1994) Preparation and clinical evaluation of 99mTc-DMSA for tumor scintigraphy. Eur J Nucl Med 21:82–85
14. Henze M, Mohammed A, Schlemmer HP, Herfarth KK, Hoffner S, Haufe S, Mier W, Eisenhut M, Debus J, Haberkorn U (2004) PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis. J Nucl Med 45:579–586
15. Deltuva V, Bunevicius A, Jurkiene N, Kulakiene I, Tamasauskas A (2012) Perioperative single photon emission computed tomography in predicting survival of malignant glioma patients. Oncol Lett 4:739–744
16. Byrne TN (1994) Imaging of gliomas. Semin Oncol 21:162–171
17. Chen W (2007) Clinical applications of PET in brain tumors. J Nucl Med 48:1468–1481
18. Benard F, Romsa J, Hustinx R (2002) Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 33:148–162
19. Soler C, Beauchesne P, Maatougui K, Schmitt T, Barral FG, Michel D, Dubois F, Brunon J (1998) Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy. Eur J Nucl Med 25:1649–1657
20. Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K (1997) Technetium-99m (V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. J Nucl Med 38:1741–1749
21. Yoshii Y, Satou M, Yamamoto T, Yamada Y, Hyodo A, Nose T, Ishikawa H, Hatakeyama R (1993) The role of thallium-201 single photon emission tomography in the investigation and characterisation of brain tumours in man and their response to treatment. Eur J Nucl Med 20:39–45
22. Semba T, Sugawara Y, Ochi T, Fujii T, Mochizuki T, Ohnishi T (2006) Thallium-201 SPECT in prognostic assessment of malignant gliomas treated with postoperative radiotherapy. Ann Nucl Med 20:287–294
23. Kosuda S, Fujii H, Aoki S, Suzuki K, Tanaka Y, Nakamura O, Shitara N (1994) Prediction of survival in patients with suspected recurrent cerebral tumors by quantitative thallium-201 single photon emission computed tomography. Int J Radiat Oncol Biol Phys 30:1201–1206
24. Vos MJ, Berkhof J, Hoekstra OS, Bosma I, Sizoo EM, Heimans JJ, Reijneveld JC, Sanchez E, Lagerwaard FJ, Buter J, Noske DP, Postma TJ (2012) MRI and thallium-201 SPECT in the prediction of survival in glioma. Neuroradiology 54:539–546
25. Costa BM, Caeiro C, Guimarães I et al (2010) Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: a Portuguese multicentre study. Oncol Rep 23:1655–1662